NCT02349672View on ClinicalTrials.gov

Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels)

CompletedOBSERVATIONAL
Enrollment

39

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Hypoxic Ischemic Encephalopathy
Interventions
PROCEDURE

blood sample

Blood will be collected to test for concentrations of UCH-L1 and GFAP.

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

American Heart Association

OTHER

lead

University of Florida

OTHER

NCT02349672 - Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (Control Levels) | Biotech Hunter | Biotech Hunter